This Horizon Europe Research and Innovation Action funds development and testing of innovative models for earlier, more precise, and more integrated palliative care for people with cancer. It targets better support for patients, carers, and clinicians through person-centred care models, digital remote tools, real-time communication, and referral guidance. The expected outcome is improved quality of life and more effective palliative care delivery in real-world settings.
Go / No-Go Memo
This opportunity looks relevant, but the strongest path is likely through a partner or consortium.
Partner
The topic is health-focused and includes digital tools, clinical studies, and implementation research, which creates some strategic relevance for Movement health actors. However, the source does not clearly establish eligibility or a realistic participation pathway for IFRC or National Societies, and it is primarily a research call.
Strategic fit
strong
Academic is the strongest profile match at 85/100; relevance is 38/100.
Eligibility risk
moderate
Eligible applicant types include "> General conditions 1. Admissibility Conditions: Proposal page limit and layout described in Annex A and Annex E of the Horizon Europe Work Programme General Annexes. Proposal page limits and layout: described in Part B of the Application Form available in the Submission System. 2. Eligible Countries described in Annex B of the Work Programme General Annexes. A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide . 3. Other Eligible Conditions Subject to restrictions for the protection of European communication networks. described in Annex B of the Work Programme General Annexes. 4. Financial and operational capacity and exclusion described in Annex C of the Work Programme General Annexes. 5a. Evaluation and award: Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes. 5b. Evaluation and award: Submission and evaluation processes The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 4 (Implementation). The cumulative threshold is 12. are described in Annex F of the Work Programme General Annexes and the Online Manual . 5c. Evaluation and award: Indicative timeline for evaluation and grant agreement described in Annex F of the Work Programme General Annexes. 6. Legal and financial set-up of the grants Eligible costs will take the form of a lump sum as defined in the Decision of 7 July 2021 authorising the use of lump sum contributions under the Horizon Europe Programme – the Framework Programme for Research and Innovation (2021-2027) – and in actions under the Research and Training Programme of the European Atomic Energy Community (2021-2025) [[This decision is available on the Funding and Tenders Portal, in the reference documents section for Horizon Europe, and others.
Deadline feasibility
moderate
The call closes in 6 days, so proposal capacity is the main constraint.
Funding attractiveness
strong
The tracked ceiling is €15M across 3 awards.
Partnership need
moderate
This may be stronger with a Academic lead or co-applicant based on fit scores.
Recommended next action
Track
Expected Outcome
Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes:
Patients will benefit from better access to earlier, more person-centred palliative care models including digital remote tools and options for home-based care.
Carers will benefit from real-time information tools and better communication.
Clinicians will benefit from guidelines on optimal patient referral and care predictions.
Scope
This topic will contribute to the achievement of the EU Cancer Mission’s objective to provide better quality of life for cancer patients, their families and carers. The focus is on the development of innovative models for earlier, more precise and better integrated palliative care. According to an EU conference on innovative palliative care for people with cancer on 8 October 2024 [1] , palliative care has big potential but such interventions come much too late and are often imprecise. Palliative care is needed very early after cancer diagnosis with the best possible information on patient wishes and effective communication between all involved carers. Barriers also include the insufficient workforce allocation, insufficient retention and resilience of staff, incorrect transferals between care facilities, regional inequities and higher needs for home-based care. In order to improve the access to palliative care, innovative models for earlier, more precise and more patient-centred care should be developed. These models should be built on patients’ needs and the consideration of all possible care options. They should use AI and digital remote tools to empower clinicians, and to deliver well-integrated care with optimal care predictions. Proposals should address most of the following:
Develop innovative models for earlier, more precise/personalised and integrated palliative care, including digital remote tools, to predict patients’ care preferences, to assign clear roles of carers and to avoid obstacles such as insufficient or inequal access.
Testing and validation of these models in real-world settings through implementation research and clinical trials. Age, sex and gender differences should be duly considered.
Attention should be given to address staff training, roles and adherence of conditions.
Usage of AI and digital remote tools (such as explanatory videos, messaging, etc.) to allow real-time communication and to predict care needs and resources.
Adoption of guidelines for optimal referrals, efficient and sustainable workforce allocation and retention (access to & dissemination of the guidelines should be provided through the future European Cancer Patient Digital Centre).
Collaboration with EU4Health projects to create synergies and to facilitate implementation. Successful proposals will be asked to join the 'Quality of Life' project cluster of the EU Cancer Mission [2] . and should include a budget for networking, attendance at meetings and joint activities [3] . The Commission will facilitate coordination of these activities. Applicants should provide details of the clinical studies in the dedicated annex using the template provided in the submission system. [1] RESEARCH AND INNOVATION
Innovative Palliative Care for People with Cancer Conference [2] In order to address the objectives of the EU Cancer Mission, participants will collaborate in project clusters to leverage EU-funding, increase networking across sectors and disciplines, and establish a portfolio of Cancer Mission R&I and policy actions [3] examples of these activities are research or research capacity, organising joint workshops, establishing best practices, joint communication or citizen engagement activities with projects funded under other clusters and pillars of Horizon Europe, or other EU programmes, as appropriate. Proposals are not required to include details of these activities, as they will be defined during the grant agreement preparation and during the life of the project.
Health Systems StrengtheningMaternalChild & Reproductive HealthResearchEvidence & LearningDigital HealthHealth SystemsMental Health
This cooperative agreement funds programming and network support for American Spaces across Armenia, including education, English language learning, digital readiness, STEM, entrepreneurship, and responsible use of emerging technologies. It is intended for eligible higher education institutions and nonprofit organizations to implement activities at the listed American Space sites. The expected outcome is expanded access to high-quality U.S.-aligned learning and engagement opportunities for Armenian communities.
This is an education and public diplomacy cooperative agreement in Armenia, not a humanitarian, health, or disaster-focused opportunity. Eligibility is limited to specific U.S.-type academic and nonprofit institutions, and there is no clear implementation pathway for IFRC or National Societies.
This cooperative agreement supports public health systems in India to prevent, detect, and respond to infectious disease threats. It focuses on strengthening public health workforce capacity, disease surveillance, laboratory systems, emergency preparedness and response, and antimicrobial resistance, with a One Health approach. The effort is intended to help control outbreaks at their source and improve overall health security capacity.
The opportunity is relevant to health security, surveillance, and outbreak response, but it is limited to India and appears oriented toward government/public-health system strengthening. It is open to several U.S.-style applicant types, yet there is no explicit indication that IFRC or National Societies are intended applicants or partners.
Track
Disasters & CrisesPreparedness for ResponseHealth Systems Strengthening
This cooperative agreement supports strengthening and sustaining public health systems in Ghana to improve prevention, early detection, and response to infectious disease threats. It funds work on laboratory capacity, surveillance, emergency response, workforce development, and sequencing/bioinformatics, with an emphasis on border districts and rapid detection of public health threats. The expected outcome is a more resilient national system able to better prevent avoidable epidemics and respond effectively to threats.
The opportunity is highly relevant thematically for public health security and surveillance, but it is country-specific to Ghana and appears structured as a CDC cooperative agreement with eligibility that may favor U.S. and partner institutions. No explicit route for IFRC or National Societies is provided, so strategic relevance is only moderate.
Track
Disasters & CrisesPreparedness for ResponseDisease Surveillance